Correlation Between Pfizer and 05526DBF1

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and 05526DBF1 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and 05526DBF1 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and B A T, you can compare the effects of market volatilities on Pfizer and 05526DBF1 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of 05526DBF1. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and 05526DBF1.

Diversification Opportunities for Pfizer and 05526DBF1

0.48
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Pfizer and 05526DBF1 is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and B A T in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 05526DBF1 and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with 05526DBF1. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 05526DBF1 has no effect on the direction of Pfizer i.e., Pfizer and 05526DBF1 go up and down completely randomly.

Pair Corralation between Pfizer and 05526DBF1

Considering the 90-day investment horizon Pfizer Inc is expected to generate 0.81 times more return on investment than 05526DBF1. However, Pfizer Inc is 1.24 times less risky than 05526DBF1. It trades about -0.12 of its potential returns per unit of risk. B A T is currently generating about -0.14 per unit of risk. If you would invest  2,871  in Pfizer Inc on September 12, 2024 and sell it today you would lose (314.00) from holding Pfizer Inc or give up 10.94% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc  vs.  B A T

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
05526DBF1 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days B A T has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Bond's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for B A T investors.

Pfizer and 05526DBF1 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and 05526DBF1

The main advantage of trading using opposite Pfizer and 05526DBF1 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, 05526DBF1 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 05526DBF1 will offset losses from the drop in 05526DBF1's long position.
The idea behind Pfizer Inc and B A T pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Commodity Directory
Find actively traded commodities issued by global exchanges
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities